German company Fresenius buys Liberty Dialysis for $2.1 billion - The Seattle Times PDF Print
The Seattle Times
The Mercer Island company, which is expected to have sales of $1 billion this year, will continue to operate under the Liberty Dialysis and Renal Advantage names after Fresenius buys it. No job losses are expected. By Melissa Allison Times,

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.